Natalizumab

Red

Brand Name(s):Tysabri

Indication:Multiple Sclerosis

Rationale:1,2,8

Considered:Sep-07

Review Date:May-21

Comments:
Drug Safety Update
Progressive multifocal leukoencephalopathy—updated advice to support early detection
April 16
…………………………
Oct 2014
NICE CG186 Management of MS in Primary & Secondary Care:
http://www.nice.org.uk/guidance/cg186/resources/guidance-multiple-sclerosis-pdf
…………………………

MHRA Drug Safety Update Volume 3 Issue 8 March 2010

NICE technology appraisal August 2007 TA127